Weekly Paclitaxel for Pregnancy Associated Breast Cancer

Serena Girardelli1, Barbara Bonomo2, Margherita Papale1

  • 1Obstetrics and Gynecology Department, I.R.C.C.S. San Raffaele Scientific Institute, Vita-Salute University, Milan, Italy.

Clinical Breast Cancer
|January 11, 2024
PubMed
Summary

Weekly paclitaxel is a safe and effective chemotherapy option for pregnant patients with breast cancer (PrBC). This treatment allows for close monitoring and can be used in both adjuvant and neoadjuvant settings.